Spots Global Cancer Trial Database for Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma
Official Title: A Phase III Randomized, Placebo Controlled, Double Blind Trial of Sorafenib Plus Erlotinib vs. Sorafenib Plus Placebo as First Line Systemic Treatment for Hepatocellular Carcinoma (HCC)
Study ID: NCT00901901
Conditions
Study Description
Brief Summary: This is a randomized trial to evaluate the clinical benefit of sorafenib 400 mg twice daily and erlotinib 150 mg once a day versus sorafenib 400 mg twice daily and placebo erlotinib once daily in subjects with unresectable advanced or metastatic Child-Pugh A HCC. Patients who are candidates for potentially curative intervention (i.e. surgical resection or local ablation) are not eligible for this study.
Detailed Description: European quality of life scale (5 dimensions) (EQ-5D)
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
, San Francisco, California, United States
, Washington, District of Columbia, United States
, Gainesville, Florida, United States
, Miami, Florida, United States
, Atlanta, Georgia, United States
, Honolulu, Hawaii, United States
, Maywood, Illinois, United States
, Westwood, Kansas, United States
, Louisville, Kentucky, United States
, New Orleans, Louisiana, United States
, Baltimore, Maryland, United States
, Boston, Massachusetts, United States
, Boston, Massachusetts, United States
, Worcester, Massachusetts, United States
, Detroit, Michigan, United States
, Minneapolis, Minnesota, United States
, New York, New York, United States
, Rochester, New York, United States
, Valhalla, New York, United States
, Charlotte, North Carolina, United States
, Philadelphia, Pennsylvania, United States
, Houston, Texas, United States
, Seattle, Washington, United States
, Randwick, New South Wales, Australia
, Brisbane, Queensland, Australia
, Herston, Queensland, Australia
, Clayton, Victoria, Australia
, Melbourne, Victoria, Australia
, Nedlands, Western Australia, Australia
, Wien, , Austria
, Bruxelles - Brussel, , Belgium
, Edegem, , Belgium
, Gent, , Belgium
, Kortrijk, , Belgium
, La Louviere, , Belgium
, Leuven, , Belgium
, Liege, , Belgium
, Belo Horizonte, Minas Gerais, Brazil
, Porto Alegre, Rio Grande Do Sul, Brazil
, São Paulo, Sao Paulo, Brazil
, Rio de Janeiro, , Brazil
, Sao Paulo, , Brazil
, Sao Paulo, , Brazil
, Plovdiv, , Bulgaria
, Sofia, , Bulgaria
, Varna, , Bulgaria
, Varna, , Bulgaria
, Edmonton, Alberta, Canada
, Montreal, Quebec, Canada
, Santiago, , Chile
, Santiago, , Chile
, Guangzhou, Guangdong, China
, Nanjing, Jiangsu, China
, Hangzhou, Zhejiang, China
, Beijing, , China
, Beijing, , China
, Floridablanca, , Colombia
, Medellín, , Colombia
, Bordeaux, , France
, Clichy, , France
, Creteil, , France
, La Roche Sur Yon, , France
, Lille, , France
, Lyon, , France
, Marseille, , France
, Paris, , France
, Pessac, , France
, Vandoeuvre-les-nancy, , France
, Villejuif, , France
, Freiburg, Baden-Württemberg, Germany
, Tübingen, Baden-Württemberg, Germany
, München, Bayern, Germany
, Regensburg, Bayern, Germany
, Frankfurt, Hessen, Germany
, Hannover, Niedersachsen, Germany
, Essen, Nordrhein-Westfalen, Germany
, Köln, Nordrhein-Westfalen, Germany
, Mainz, Rheinland-Pfalz, Germany
, Homburg, Saarland, Germany
, Berlin, , Germany
, Athens, , Greece
, Larissa, , Greece
, Thessaloniki, , Greece
, Thessaloniki, , Greece
, Hong Kong, , Hong Kong
, Shatin, , Hong Kong
, Beer Sheva, , Israel
, Haifa, , Israel
, Petah Tikva, , Israel
, Rehovot, , Israel
, Zrifin, , Israel
, Milano, Lombardia, Italy
, Goyang-si, Gyeonggido, Korea, Republic of
, Seoul, , Korea, Republic of
, Seoul, , Korea, Republic of
, Seoul, , Korea, Republic of
, Seoul, , Korea, Republic of
, Auckland, , New Zealand
, Christchurch, , New Zealand
, Wellington South, , New Zealand
, Lima, , Peru
, Lima, , Peru
, Bydgoszcz, , Poland
, Gdansk, , Poland
, Gliwice, , Poland
, Warszawa, , Poland
, Barnaul, , Russian Federation
, Moscow, , Russian Federation
, Nizhny Novgorod, , Russian Federation
, Singapore, , Singapore
, Singapore, , Singapore
, Johannesburg, Gauteng, South Africa
, Cape Town, Western Cape, South Africa
, Hospitalet de Llobregat, Barcelona, Spain
, Barcelona, , Spain
, Lugo, , Spain
, Madrid, , Spain
, Santander, , Spain
, Valencia, , Spain
, Valencia, , Spain
, Tainan, , Taiwan
, Taipei, , Taiwan
, Taoyuan, , Taiwan
, Sheffield, South Yorkshire, United Kingdom
, Glasgow, , United Kingdom
, London, , United Kingdom
, Newcastle Upon Tyne, , United Kingdom
Contact Details
Name: Bayer Study Director
Affiliation: Bayer
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
